Swiss National Bank Aptinyx Inc. Transaction History

Swiss National Bank

  • $143 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 02, 2019
SELL
$2.95 - $4.38 $80,830 - $120,012
-27,400 Closed
0 $0
Q1 2019

May 10, 2019
BUY
$3.99 - $19.33 $50,274 - $243,557
12,600 Added 85.14%
27,400 $111,000
Q4 2018

Feb 13, 2019
BUY
$16.15 - $28.93 $239,019 - $428,164
14,800 New
14,800 $245,000

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email